S1 Technology
Own Original Technology
- Composite bone grafting material composed of chemically and structurally treated
- hydroxyapatite and additives with a natural structure similar to human bone,
- it has osteoconductive property to help bone regeneration at the grafted site.
- Core technology applicable to all medical fields (orthopedics, neurology, dentistry, etc.)
- and raw materials (xenogeneic, allogeneic, synthetic)
Facility
1, 2, 3 Factory construction completed
World's First, The European CE certificate of 3 items Separate biomaterial
manufacturing facilities for different raw materials in factory 1~3
-
1st Factory / HQ
[Bone Graft Material Line]
-
2nd Factory / R&D Center
[Bone Graft + Collagen Line]
-
3rd Factory
[Artificial Skin + Other Medical Field]
R&D Facilities / Certifications / Patents
Commercialized technology Global IP (intellectual property rights)
holding a total of 46 or more
Overseas
23
PCT application
2US application
6European application
6China application
6Taiwan application
5Madrid trademark application
1Chinese design application
1
0or more in total
Domestic